Shingles vaccine: effective and costly or cost-effective?
Koplan
Jeffrey P
JP
Harpaz
Rafael
R
D003362:Cost-Benefit Analysis; D006562:Herpes Zoster / Q000517:prevention & control*; D014645:Herpesvirus 3, Human / Q000276:immunology*; D022283:Herpesvirus Vaccines / Q000191:economics* / Q000627:therapeutic use; D006801:Humans; D051474:Neuralgia, Postherpetic / Q000517:prevention & control*
D022283:Herpesvirus Vaccines